These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17190738)

  • 1. FK506: an immunosuppressive agent preserving HIF-1 activity.
    Kim KE; Jung YJ; Yeo EJ; Chun YS; Park JW
    Immunopharmacol Immunotoxicol; 2006; 28(4):609-20. PubMed ID: 17190738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of miniature pig HIF-1alpha and its responses to immunosuppressive agents.
    Kim KE; Jung YJ; Li SH; Chun YS; Ahn C; Park JW
    Immunopharmacol Immunotoxicol; 2008; 30(1):105-15. PubMed ID: 18306108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506, but not cyclosporin A, prevents mitochondrial dysfunction during hypoxia in rat hepatocytes.
    Kaibori M; Inoue T; Tu W; Oda M; Kwon AH; Kamiyama Y; Okumura T
    Life Sci; 2001 May; 69(1):17-26. PubMed ID: 11411802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.
    Wai LE; Fujiki M; Takeda S; Martinez OM; Krams SM
    Transplantation; 2008 Jan; 85(1):145-9. PubMed ID: 18192925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes.
    Kaibori M; Sakitani K; Oda M; Kamiyama Y; Masu Y; Nishizawa M; Ito S; Okumura T
    J Hepatol; 1999 Jun; 30(6):1138-45. PubMed ID: 10406194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation.
    Deppe CE; Heering PJ; Viengchareun S; Grabensee B; Farman N; Lombès M
    Endocrinology; 2002 May; 143(5):1932-41. PubMed ID: 11956176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CREB- and cAMP response element-mediated gene transcription by the immunosuppressive drugs cyclosporin A and FK506 in T cells.
    Krüger M; Schwaninger M; Blume R; Oetjen E; Knepel W
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):433-40. PubMed ID: 9349628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin.
    Cardenas ME; Zhu D; Heitman J
    Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):472-7. PubMed ID: 8591053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes.
    Mojsilovic-Petrovic J; Callaghan D; Cui H; Dean C; Stanimirovic DB; Zhang W
    J Neuroinflammation; 2007 May; 4():12. PubMed ID: 17474992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line.
    Schwaninger M; Blume R; Oetjen E; Knepel W
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):541-5. PubMed ID: 7509460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of FK506 on graft coronary disease of rat cardiac allograft--a comparison with cyclosporine.
    Arai S; Teramoto S; Senoo Y
    J Heart Lung Transplant; 1992; 11(4 Pt 1):757-62. PubMed ID: 1379829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the mechanism of action of cyclosporine and FK506.
    Tocci MJ; Sigal NH
    Curr Opin Nephrol Hypertens; 1992 Dec; 1(2):236-42. PubMed ID: 1285380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1alpha accumulation upregulates MICA and MICB expression on human cardiomyocytes and enhances NK cell cytotoxicity during hypoxia-reoxygenation.
    Wei L; Lu J; Feng L; Long D; Shan J; Li S; Li Y
    Life Sci; 2010 Jul; 87(3-4):111-9. PubMed ID: 20566410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of cyclosporine a and FK506 on potassium transport systems in MDCK cells.
    Aker S; Heering P; Kinne-Saffran E; Deppe C; Grabensee B; Kinne RK
    Exp Nephrol; 2001; 9(5):332-40. PubMed ID: 11549851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.
    Cho CS; Chang Z; Elkahwaji J; Scheunemann TL; Manthei ER; Colburn M; Knechtle SJ; Hamawy MM
    Int Immunol; 2003 Nov; 15(11):1369-78. PubMed ID: 14565935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular signaling mechanisms for stimulation of growth hormone secretion and growth hormone primary transcripts by immunosuppressant agents, FK506 and cyclosporin A, in cultured rat pituitary cells.
    Ohye H; Sato M; Murao K; Matsubara S; Tokuda M; Takahara J
    Neuroimmunomodulation; 1998; 5(6):309-17. PubMed ID: 9762012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin a and tacrolimus (FK506) differentially alter T-cell receptor expression in vivo.
    Miller JL; Ericson SG
    Immunopharmacol Immunotoxicol; 2007; 29(1):105-18. PubMed ID: 17464771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A, but not FK506, increases arachidonic acid release and inhibits proliferation of pituitary corticotrope tumor cells.
    Pompeo A; Baldassare M; Luini A; Buccione R
    Life Sci; 1999; 64(10):837-46. PubMed ID: 10096434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.
    Miyazaki M; Fujikawa Y; Takita C; Tsumura H
    Clin Rheumatol; 2007 Feb; 26(2):231-9. PubMed ID: 16586042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.